These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 37350788)

  • 1. Development of virus-like particles with inbuilt immunostimulatory properties as vaccine candidates.
    Collett S; Earnest L; Carrera Montoya J; Edeling MA; Yap A; Wong CY; Christiansen D; Roberts J; Mumford J; Lecouturier V; Pavot V; Marco S; Loi JK; Simmons C; Gulab SA; Mackenzie JM; Elbourne A; Ramsland PA; Cameron G; Hans D; Godfrey DI; Torresi J
    Front Microbiol; 2023; 14():1065609. PubMed ID: 37350788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design.
    Urakami A; Ngwe Tun MM; Moi ML; Sakurai A; Ishikawa M; Kuno S; Ueno R; Morita K; Akahata W
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28956764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric Hepatitis B core virus-like particles harboring SARS-CoV2 epitope elicit a humoral immune response in mice.
    Sazegari S; Akbarzadeh Niaki M; Afsharifar A; Niazi A; Derakhshandeh A; Moradi Vahdat M; Hemmati F; Eskandari MH
    Microb Cell Fact; 2023 Feb; 22(1):39. PubMed ID: 36841778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virus-like particle secretion and genotype-dependent immunogenicity of dengue virus serotype 2 DNA vaccine.
    Galula JU; Shen WF; Chuang ST; Chang GJ; Chao DY
    J Virol; 2014 Sep; 88(18):10813-30. PubMed ID: 25008922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human metapneumovirus virus-like particles induce protective B and T cell responses in a mouse model.
    Cox RG; Erickson JJ; Hastings AK; Becker JC; Johnson M; Craven RE; Tollefson SJ; Boyd KL; Williams JV
    J Virol; 2014 Jun; 88(11):6368-79. PubMed ID: 24672031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetravalent recombinant dengue virus-like particles as potential vaccine candidates: immunological properties.
    Liu Y; Zhou J; Yu Z; Fang D; Fu C; Zhu X; He Z; Yan H; Jiang L
    BMC Microbiol; 2014 Dec; 14():233. PubMed ID: 25520151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioengineered Bovine Papillomavirus L1 Protein Virus-like Particle (VLP) Vaccines for Enhanced Induction of CD8 T Cell Responses through Cross-Priming.
    Viscidi RP; Rowley T; Bossis I
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37372999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles.
    Schweneker M; Laimbacher AS; Zimmer G; Wagner S; Schraner EM; Wolferstätter M; Klingenberg M; Dirmeier U; Steigerwald R; Lauterbach H; Hochrein H; Chaplin P; Suter M; Hausmann J
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical evaluation of manufacturable SARS-CoV-2 spike virus-like particles produced in Chinese Hamster Ovary cells.
    Alpuche-Lazcano SP; Stuible M; Akache B; Tran A; Kelly J; Hrapovic S; Robotham A; Haqqani A; Star A; Renner TM; Blouin J; Maltais JS; Cass B; Cui K; Cho JY; Wang X; Zoubchenok D; Dudani R; Duque D; McCluskie MJ; Durocher Y
    Commun Med (Lond); 2023 Aug; 3(1):116. PubMed ID: 37612423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus.
    Garg H; Sedano M; Plata G; Punke EB; Joshi A
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28794019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plant-made dengue virus-like particles produced by co-expression of structural and non-structural proteins induce a humoral immune response in mice.
    Ponndorf D; Meshcheriakova Y; Thuenemann EC; Dobon Alonso A; Overman R; Holton N; Dowall S; Kennedy E; Stocks M; Lomonossoff GP; Peyret H
    Plant Biotechnol J; 2021 Apr; 19(4):745-756. PubMed ID: 33099859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plant-derived VLP: a worthy platform to produce vaccine against SARS-CoV-2.
    Hemmati F; Hemmati-Dinarvand M; Karimzade M; Rutkowska D; Eskandari MH; Khanizadeh S; Afsharifar A
    Biotechnol Lett; 2022 Jan; 44(1):45-57. PubMed ID: 34837582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dengue-2 virus-like particle (VLP) based vaccine elicits the highest titers of neutralizing antibodies when produced at reduced temperature.
    Boigard H; Cimica V; Galarza JM
    Vaccine; 2018 Nov; 36(50):7728-7736. PubMed ID: 30377067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as Adjuvant.
    Beljanski V; Chiang C; Kirchenbaum GA; Olagnier D; Bloom CE; Wong T; Haddad EK; Trautmann L; Ross TM; Hiscott J
    J Virol; 2015 Oct; 89(20):10612-24. PubMed ID: 26269188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral vector- and virus-like particle-based vaccines against infectious diseases: A minireview.
    Henríquez R; Muñoz-Barroso I
    Heliyon; 2024 Aug; 10(15):e34927. PubMed ID: 39144987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Bivalent, Spherical Virus-Like Particle Vaccine Enhances Breadth of Immune Responses against Pathogenic Ebola Viruses in Rhesus Macaques.
    Singh K; Marasini B; Chen X; Ding L; Wang JJ; Xiao P; Villinger F; Spearman P
    J Virol; 2020 Apr; 94(9):. PubMed ID: 32075939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virus-like Particle Vaccines and Platforms for Vaccine Development.
    Kheirvari M; Liu H; Tumban E
    Viruses; 2023 May; 15(5):. PubMed ID: 37243195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
    Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
    J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid screening and scaled manufacture of immunogenic virus-like particles in a tobacco BY-2 cell-free protein synthesis system.
    Armero-Gimenez J; Wilbers R; Schots A; Williams C; Finnern R
    Front Immunol; 2023; 14():1088852. PubMed ID: 36776898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung CD8+ T Cell Impairment Occurs during Human Metapneumovirus Infection despite Virus-Like Particle Induction of Functional CD8+ T Cells.
    Wen SC; Schuster JE; Gilchuk P; Boyd KL; Joyce S; Williams JV
    J Virol; 2015 Sep; 89(17):8713-26. PubMed ID: 26063431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.